Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05852977

Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion Island

Study of Dengue in Patients With Autoimmune Diseases With or Without Immunosuppressive Treatment During the Epidemics of 2020 and 2021 in Reunion Island

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is not known whether there is a different clinical profile of dengue in patients with immune system dysfunction. Preliminary data and previous literature suggest that autoimmune diseases, and in particular their treatment, may favour the evolution to severe forms of dengue. Our research hypothesis is that the clinico-biological presentation of dengue might be different in case of autoimmune disease, either on the side of overactivation (autoimmune and auto inflammatory diseases without treatment) or immunodepression (autoimmune and auto inflammatory diseases under immunosuppressive treatment).

Conditions

Timeline

Start date
2023-06-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2023-05-10
Last updated
2023-05-10

Source: ClinicalTrials.gov record NCT05852977. Inclusion in this directory is not an endorsement.